ASTERDM - IntraDay Trade Analysis

Last Updated Time : 02 Aug 25, 12:58 am

IntraDay Trade Rating: 2.8

🧪 Intraday Trading Analysis for ASTERDM (Aster DM Healthcare Ltd.)

Aster DM shows mixed-to-weak potential for intraday trading today. While the stock has had strong quarterly profit growth and is trading above key moving averages, its high valuation, low volume, and neutral momentum indicators suggest caution. The setup lacks strong intraday triggers unless momentum improves during the session.

🔍 Key Technical & Fundamental Insights

📊 Technical Overview

RSI at 49.9: Neutral — no clear momentum.

MACD at +0.58: Weak bullish signal — lacks strength.

Current Price ₹592 > DMA50 ₹579 and DMA200 ₹508: Technically above support zones.

Volume Today (3.9L) < Avg Vol 1Wk (8.75L): Weak participation — low intraday interest.

52w Index at 75.4%: Strong relative strength — near yearly highs.

📈 Fundamental Snapshot

EPS ₹108 vs. P/E 76.9: Overvalued — premium pricing.

PEG Ratio -8.78: Negative — unreliable growth valuation.

ROCE 10.7% & ROE 10.5%: Moderate efficiency.

Debt-to-Equity 0.59: Slightly leveraged.

PAT Qtr ₹98.6 Cr vs. Prev Qtr ₹70 Cr: Strong sequential growth.

Qtr Profit Var +136%: Excellent YoY growth.

FII Holding Change -2.02%: Foreign exit — sentiment drag.

DII Holding Change +0.70%: Mild domestic support.

🛒 Optimal Buy Price for Intraday

Buy Zone: ₹588–₹593 Entry only if volume spikes above 6L and RSI crosses 52+

🎯 Exit Strategy

Profit-Taking Levels

Target 1: ₹605 — minor resistance zone

Target 2: ₹615 — upper band of recent consolidation

Stop-Loss / Loss Protection

Stop-Loss: ₹580 — below DMA50 and psychological ₹585 level

📉 If You Already Hold the Stock Today

Exit on Weakness

RSI drops below 48 or MACD turns negative

Price fails to hold above ₹590 by mid-session (around 1:00 PM IST)

Volume Watch

If volume remains below 5L and price stalls near ₹595, consider exit

Momentum Exit Strategy

If price hits ₹605+, trail stop-loss upward by ₹8–₹10 increments

Exit fully if price reverses from ₹615+ with rising sell pressure

Would you like a shortlist of mid-cap healthcare stocks with stronger intraday volume and RSI setups for better trading opportunities today?

Edit in a page